Patently-O

DECEMBER 19, 2024

Like Judge Reyna's decision in EcoFactor , the case involves the use of lump-sum licenses to create a running royalty calculation, as well as the proper approach to apportioning damages so that the award is for the use of the patented invention. Continue reading this post on Patently-O.

Patent 59

Patent Licensing Invention 59

SpicyIP

JUNE 3, 2024

The treaty’s implications vary based on two hypothetical scenarios for India: Scenario 1- Technological Boom by 2030-35 in India especially for domestic Indian Patents : If India achieves significant technological advancements, patents owned by Indian entities may gain high demand in developed nations.

Intellectual Property 119

Intellectual Property Due Diligence Intellectual Property Law Technology 119

U.S. Department of Commerce

OCTOBER 13, 2022

It is projected that by 2030, one out of five workers will be Latino. This pursuit of equity is not just the right thing to do – it’s the right thing to do for our economy. America has over 4.7 million Latino-owned businesses that contribute $800 billion to our economy each year. Take a moment to read these powerful blogs.

Business 108

Business Inventor Invention Technology 108

The IPKat

DECEMBER 20, 2023

The SPC on the composition of matter case for secukinumab expires in 2030. The case law relating to pointers and selection inventions is well established CLBA, II-E-1.6.2c) ). Secukinumab is marketed by Novartis in Europe as Cosentyx for a number of inflammatory diseases, including psoriasis and ankylosing spondylitis (AS).

Patent 111

Patent Invention Patent Drafting Patent Application 111

Patently-O

SEPTEMBER 27, 2023

Leaders realize that the next big invention can emerge from unexpected quarters at their businesses, and many have begun casting the net as wide as possible. billion by 2030. Achieving this end at a company means having all perspectives involved in the inventing and patenting processes. This time around is different.

Inventor 116

Inventor Business Moral Rights Technology 116

Patently-O

APRIL 15, 2023

In 2007, UCB invented and marketed “original Neupro,” a transdermal patch for the treatment of Parkinson’s disease containing a dispersion of amorphous rotigotine and polyvinylpyrrolidone (PVP), with the PVP functioning as a stabilizer. If the drug crystallizes in the patch, it will generally not be able to cross the skin barrier.

Art 81

Art Patent Marketing Marketing 81

SpicyIP

OCTOBER 1, 2024

The FERs for all five applications detail issues on the accounts of novelty, inventiveness, non-patentability and sufficiency of disclosure as raised in the GPOs. Moreover, it is not like the First Examination Reports (FERs) of these applications released by the IPO don’t call out exactly these issues with the patent applications.

Patent Application 124

Patent Application Patent Licensing Reporting 124